RESUMEN
Although glucocorticoids inhibit inflammation and are used to treat painful inflammatory rheumatic diseases, the contribution, if any, of endogenous pituitary-adrenocortical activity to the control of pain remains unclear. We report that injection of dilute formalin into the hindpaw not only evokes inflammation and pain-related behavior, but it also increases ACTH and corticosterone to a greater extent than restraint and saline injection alone. This difference was particularly robust during the final periods of pain-related behavior in the formalin test, when the ACTH and corticosterone (B) levels in the restraint/saline control group had returned to normal. These results indicate that formalin-evoked increases in ACTH and B reflect nociceptive input, rather than the stress associated with handling. To test the hypothesis that the formalin-induced increase in corticosterone reduces pain and inflammation, we next evaluated the effect of adrenalectomy (to prevent activation of glucocorticoid receptors) or high-dose dexamethasone (to saturate glucocorticoid receptors) on nociceptive processing in the formalin test. Neither adrenalectomy nor dexamethasone changed behavioral or cardiovascular nociceptive responses. Furthermore, the increases in blood pressure and heart rate produced by formalin may not be mediated by adrenomedullary catecholamine release. In addition, we conclude that the nociceptive component of the formalin stimulus is sufficient to activate the pituitary-adrenocortical system in the awake rat, but that the resulting release of corticosterone does not feed back and reduce nociceptive processing.
Asunto(s)
Corteza Suprarrenal/fisiología , Corticosterona/fisiología , Formaldehído/farmacología , Nociceptores/fisiología , Hipófisis/fisiología , Adrenalectomía , Hormona Adrenocorticotrópica/sangre , Animales , Conducta Animal/efectos de los fármacos , Presión Sanguínea/efectos de los fármacos , Corticosterona/sangre , Dexametasona/farmacología , Glucocorticoides/farmacología , Frecuencia Cardíaca/efectos de los fármacos , Inflamación/inducido químicamente , Masculino , Dolor , Ratas , Ratas Sprague-DawleyRESUMEN
Limitations of presently available testosterone esters (enanthate and cypionate) include the fluctuating serum testosterone levels and the need for relatively frequent injections (every 10-21 days). These limitations of testosterone esters have prompted the development of more physiological and longer acting systems for androgen delivery. This paper reports pharmacokinetic and pharmacodynamic data with a second generation long-acting testosterone microcapsule formulation in hypogonadal men. This was a single dose, open label, nonrandomized study. Ten hypogonadal men with primary (n = 6) or secondary (n = 4) hypogonadism, otherwise in good health, received 630 mg microencapsulated testosterone in dextran solution (IM) on day 1. Serum total and free testosterone; LH; FSH; dihydrotesterone; estradiol; sex hormone-binding globulin; total cholesterol; high, low, and very low density lipoprotein cholesterol; triglycerides; and apoprotein-AII and -B were measured on multiple occasions during the 2-week control period and the 16-week treatment period. In addition, on days 0, 1, 28, 56, and 84, subjects were hospitalized for detailed hormone analyses over the 24-h period. Serum total and free testosterone levels rose quickly into the midnormal range and stayed uniformly in the eugonadal range for about 70-77 days, after which serum testosterone levels declined gradually into the hypogonadal range. Testosterone release from the microcapsule formulation over the first 10 weeks approximated zero order kinetics. Serum dihydrotestosterone levels rose into the normal range, and testosterone to dihydrotestosterone ratios remained in the physiological range. Serum estradiol levels rose and stayed in the midnormal male range. Serum sex hormone-binding globulin levels decreased significantly during treatment. Serum LH and FSH levels also significantly decreased in the six hypergonadotropic men. Total cholesterol low and very low density lipoprotein cholesterol and triglyceride levels did not change, but plasma high density lipoprotein cholesterol levels decreased significantly during treatment. These data indicate that testosterone microcapsule formulation provides uniform eugonadal levels of testosterone for about 10 weeks. The long duration and zero order kinetics make it an attractive alternative to existing methods of androgen replacement.
Asunto(s)
Hipogonadismo/tratamiento farmacológico , Testosterona/administración & dosificación , Adolescente , Adulto , Biodegradación Ambiental , Disponibilidad Biológica , Composición de Medicamentos , Hormonas Esteroides Gonadales/sangre , Humanos , Hipogonadismo/sangre , Inyecciones , Lípidos/sangre , Masculino , Persona de Mediana Edad , Testosterona/sangre , Testosterona/uso terapéutico , Factores de TiempoRESUMEN
Injection of formalin in the rat hindpaw produces two phases of nociceptive behavior. Although it is generally agreed that the first phase results from direct chemical activation of nociceptive primary afferent fibers, the factors that contribute to the second phase are not established. In the present study, we monitored the expression of the c-fos protein to evaluate whether the pattern of activity of dorsal horn neurons differs as a result of ongoing afferent activity during the two phases. To selectively block the first or second phase, we respectively used remifentanil, a potent and short acting opiate agonist, and QX-314, a quaternary derivative of lidocaine, which does not cross the blood brain barrier. We also evaluated the effect of eliminating nociceptive behavior in both phases using both remifentanil and lidocaine or a combination of local anesthetics, bupivicaine and quaternary lidocaine. In all groups, formalin (5%, 50 microliters) was injected subcutaneously into the plantar surface of the hindpaw. To assess the nociceptive behavior produced by formalin, we monitored the number of flinches. Injection of remifentanil during the first phase completely blocked the first phase formalin-evoked nociceptive behavior, and had no effect on the second phase. Injection of lidocaine during the interphase completely blocked second phase nociceptive behavior. As expected, when remifentanil was administered during the first phase and lidocaine during the second phase, all formalin-evoked nociceptive behavior was blocked. The same was true for rats that received injections of bupivicaine and lidocaine during phases 1 and 2, respectively. In laminae I-II of the L4-L5 segment, the magnitude of the decrease in Fos expression was comparable for remifentanil (26.5%) and lidocaine (27.3%); the decrease was greater when both remifentanil and lidocaine were administered (50.5%), and even greater when bupivicaine and lidocaine were used (74.2%). In laminae V-VI, remifentanil, by itself, decreased c-fos expression by 39.4%; for lidocaine alone, the decrease was 58.4%. We did not observe further significant decreases when both remifentanil and lidocaine, or bupivacaine and lidocaine were injected (69.7% and 74.6%, respectively). Our results not only provide strong evidence that activity during the second phase is necessary for maintaining the maximal expression of c-fos in the spinal cord, but also reveal significant regional differences in the central patterns of activity generated during the two phases. These results also confirm our previous reports that c-fos expression is not eliminated when the behavioral manifestation of the noxious stimulus is completely blocked.
Asunto(s)
Analgésicos Opioides/farmacología , Anestésicos Locales/farmacología , Formaldehído , Lidocaína/farmacología , Dimensión del Dolor/efectos de los fármacos , Piperidinas/farmacología , Proteínas Proto-Oncogénicas c-fos/biosíntesis , Médula Espinal/metabolismo , Animales , Bupivacaína/farmacología , Inmunohistoquímica , Masculino , Dolor/psicología , Proteínas Proto-Oncogénicas c-fos/genética , Ratas , Ratas Sprague-Dawley , Remifentanilo , Médula Espinal/efectos de los fármacosRESUMEN
The opioid antagonist, naloxone, produces equivocal effects on the magnitude of nociceptive responses in several animal models of persistent pain, including the formalin test. Hindpaw injection of dilute formalin produces not only inflammation but also phasic (Phase 1) and persistent (Phase 2) behavioral and cardiovascular nociceptive responses in the rat. To test the hypothesis that endogenous opioid systems contribute to the magnitude of responses to intraplantar formalin injection, we evaluated the effects of continuous naloxone administration (0.01-100 mg/kg per h, i.v.) on formalin-evoked hindpaw inflammation, on behavioral indices of pain, flinching and licking pain behavior, and on changes in mean arterial pressure and heart rate. We report that naloxone, at doses less than 100 mg/kg per h, did not change any formalin-evoked response. Although the 100 mg/kg per h dose significantly decreased these responses, it also produced muscle rigidity and profound bradycardia. We conclude that endogenous opioids do not significantly modulate the nociceptive processing induced by subcutaneous formalin.
Asunto(s)
Formaldehído , Naloxona/farmacología , Antagonistas de Narcóticos/farmacología , Dolor/fisiopatología , Animales , Conducta Animal/efectos de los fármacos , Presión Sanguínea/efectos de los fármacos , Formaldehído/administración & dosificación , Frecuencia Cardíaca/efectos de los fármacos , Hemodinámica/efectos de los fármacos , Inflamación/inducido químicamente , Inflamación/patología , Infusiones Intravenosas , Inyecciones Subcutáneas , Masculino , Naloxona/administración & dosificación , Antagonistas de Narcóticos/administración & dosificación , Dolor/patología , Dolor/psicología , Ratas , Ratas Sprague-DawleyRESUMEN
Hindpaw injection of dilute formalin produces brief (Phase 1) and persistent (Phase 2) nociceptive responses in the rat. We recently showed that systemically-administered remifentanil during Phase 1 interacted with peripheral opioid receptors to delay the onset and termination of Phase 2 (Taylor et al., 1997b). To test the hypothesis that opioid inhibition of proinflammatory events during Phase 1 contributed to this delay, we evaluated the effects of remifentanil on the time course of formalin-induced inflammation. We found that formalin increased paw thickness (edema), plasma extravasation and local blood flow within minutes of its injection, i.e. during Phase 1. Each of these responses was blocked during remifentanil administration (30 microg/kg i.v. bolus, followed 90 s later with a 15 microg/kg/min infusion for 13.5 min), indicating that opioids inhibit Phase 1 inflammation. Opioid blockade of the blood flow response could be reversed with a peripherally-acting opioid antagonist, naloxone methiodide, indicating that remifentanil acted upon peripheral opioid receptors. Although the administration of remifentanil during Phase 1 did not reduce the magnitude of inflammatory responses during Phase 2, it did delay the onset and termination of edema during Phase 2. As this corresponds to the effects of remifentanil on nociceptive responses during Phase 2, we suggest that opioid analgesics act upon peripheral sites to inhibit inflammation during Phase 1, leading to a delay in the temporal profile of inflammatory (and likely nociceptive) responses during Phase 2.
Asunto(s)
Analgésicos Opioides/farmacología , Permeabilidad Capilar/efectos de los fármacos , Formaldehído/farmacología , Miembro Posterior/irrigación sanguínea , Piperidinas/farmacología , Plasma/metabolismo , Animales , Edema/inducido químicamente , Edema/patología , Miembro Posterior/diagnóstico por imagen , Inflamación/inducido químicamente , Inflamación/fisiopatología , Flujometría por Láser-Doppler , Masculino , Ratas , Ratas Sprague-Dawley , Flujo Sanguíneo Regional/efectos de los fármacos , Remifentanilo , Temperatura Cutánea/efectos de los fármacos , UltrasonografíaRESUMEN
Recent human studies suggest rapid in vivo hydrolysis of the lipid-lowering drug, pantethine, to the vitamin pantothenic acid and the small aminothiol compound, cysteamine. To test whether the active agent is a hydrolysis product, we repeated three experimental models of pantethine's effect with pantothenate and cysteamine. In vitro experiments with human fetal fibroblasts showed equivalent modulation of cholesterol and methyl sterol synthesis by pantethine, cysteamine, or cystamine (the disulfide of cysteamine), but pantothenate had no effect. Similarly, in vivo experiments with 0.5% cholesterol-fed rabbits showed oral pantethine or equimolar cystamine significantly lowered plasma cholesterol, while pantothenate, cystine, and 2-hydroxyethyl disulfide did not. Lastly, diabetic male rats (40 mg/kg streptozotocin) fed 0.1% pantethine and lower plasma free fatty acids after 2 weeks than controls, an effect not seen with pantothenate and largely duplicated by cystamine. The efficacy of pantethine has previously been attributed to altered vitamin metabolism and increased coenzyme A concentration. Pantethine did increase CoA levels 45% in rat liver homogenates while equivalent amounts of cystamine or pantothenate did not. However, a causal relationship between CoA levels and pantethine's action as a hypolipemic agent has never been shown. At least in 3 independent experimental models, the lipomodulating effect of pantethine appears instead to be mediated by the hydrolysis product cysteamine.
Asunto(s)
Cisteamina/metabolismo , Metabolismo de los Lípidos , Panteteína/farmacología , Compuestos de Sulfhidrilo/farmacología , Animales , Células Cultivadas , Coenzima A/metabolismo , Diabetes Mellitus Experimental/tratamiento farmacológico , Diabetes Mellitus Experimental/metabolismo , Humanos , Hidrólisis , Hipercolesterolemia/tratamiento farmacológico , Hipercolesterolemia/metabolismo , Masculino , Panteteína/análogos & derivados , Panteteína/metabolismo , Conejos , RatasRESUMEN
Three-dimensional (3-D) treatment planning is a labor-intensive process with contouring of the target volume and critical normal tissues being a significant time-consuming component. The use of 3-D treatment planning on a routine basis may be limited by the time required to complete treatment plans. Despite the need to increase the efficiency of the process, there is little literature addressing the speed and accuracy of contouring systems. In an attempt to initiate systematic analysis of the contouring process, data sets consisting of 10 CT images each were developed on two patients with esophageal carcinoma. Nine different operators manually contoured structures (target volume, spinal canal, lungs) on the data sets using four different contouring systems present in our department. These included both commercially available systems and those developed by the authors. There was a wide variation in the hardware and software characteristics of these systems. The time required to contour the CT data sets was recorded and analyzed. The contouring accuracy was assessed by comparison with a standard template derived from the CT data set for each image. The contouring time was found to be dependent on the system design, previous contouring experience, and the type of drawing instrument (lightpen vs mouse). The mean contouring time ranged from 26 minutes per patient for the fastest system to 41 minutes for the slowest. Potential clinically significant errors in contouring were rare for the spinal canal and lungs but present at a greater rate for the target volume (30.3%). The implications of this finding are discussed.
Asunto(s)
Neoplasias Esofágicas/radioterapia , Procesamiento de Imagen Asistido por Computador , Planificación de la Radioterapia Asistida por Computador/métodos , Adenocarcinoma/diagnóstico por imagen , Adenocarcinoma/radioterapia , Carcinoma de Células Escamosas/diagnóstico por imagen , Carcinoma de Células Escamosas/radioterapia , Neoplasias Esofágicas/diagnóstico por imagen , Humanos , Factores de Tiempo , Tomografía Computarizada por Rayos XRESUMEN
In three experiments, observers who were instructed to perceive one of two alternative depth arrangements of a three-dimensional wire cube fixated near one of two intersections that differed in the degree to which they specified the cube's veridical depth organization. In order to separate perceptual effects from experimenter effects, we measured indirect reports about variables perceptually coupled to perceived depth rather than direct reports about perceived depth. In all three experiments, reversal durations at the two intersections differed, even though the two were parts of a single object. In addition, reversals varied with viewers' intentions. Thus, the unit of perceptual organization may be smaller than the entire object, and viewers' intentions can influence the perception of real moving objects. In additional analyses, reversal durations were separated into two components: nonelective instability and malleability; the question of whether these two components of ambiguity are functionally distinct could not be decided.
Asunto(s)
Percepción de Profundidad , Percepción de Forma , Percepción de Movimiento , Humanos , Cinestesia , Ilusiones Ópticas , Orientación , Disposición en PsicologíaRESUMEN
Intraplantar injection of dilute formalin evokes brief (Phase 1) and persistent (Phase 2) increases in primary afferent activity, pain behavior, and cardiovascular responses, and induces spinal cord Fos-like immunoreactivity (Fos-LI). Although previous studies demonstrated that the destruction of small diameter primary afferents with neonatal capsaicin treatment decrease formalin-evoked nociception, these studies only evaluated behavioral responses, and did not distinguish between Phase 1 and 2. To address these questions, we simultaneously evaluated formalin-evoked pain behavior (flinching of the afflicted paw), cardiovascular responses (heart rate and mean arterial pressure), and lumbar spinal cord Fos expression in control rats and in rats treated with capsaicin (100 mg/kg) one day postpartum. We found that neonatal capsaicin-treated rats, compared to controls, exhibited similar cardiovascular responses and slightly less flinching behavior during Phase 1. During Phase 2, however, capsaicin-treated rats exhibited 59% less flinching and 45% smaller heart rate responses. Also, in capsaicin-treated rats, we counted 59% fewer Fos-labeled neurons in the spinal cord. These results indicate that capsaicin-sensitive afferents contribute to formalin-evoked behavioral and cardiovascular responses and to spinal cord neuronal responses. The differential effect of neonatal capsaicin on nociception during Phase 1 and Phase 2 suggests that sensitization mechanisms during Phase 1 do not contribute to the magnitude of nociceptive responses during Phase 2.
Asunto(s)
Conducta Animal/efectos de los fármacos , Capsaicina/farmacología , Proteínas del Tejido Nervioso/biosíntesis , Dolor/inducido químicamente , Proteínas Proto-Oncogénicas c-fos/biosíntesis , Médula Espinal/efectos de los fármacos , Vías Aferentes/efectos de los fármacos , Animales , Presión Sanguínea/efectos de los fármacos , Femenino , Frecuencia Cardíaca/efectos de los fármacos , Inmunohistoquímica , Masculino , Proteínas del Tejido Nervioso/análisis , Dimensión del Dolor/métodos , Proteínas Proto-Oncogénicas c-fos/análisis , Ratas , Ratas Sprague-Dawley , Médula Espinal/metabolismoRESUMEN
Several adrenergically active drugs have been shown to prevent the masculinizing and/or defeminizing effects of testosterone on brain sexual differentiation. We examined the ability of the neuronal norepinephrine uptake blocker, cocaine, to produce similar effects. The ability of cocaine to inhibit sex steroid incorporation into the hypothalamus during a critical period for sexual differentiation of the brain was examined in females treated at birth with testosterone. Sixty minutes after administration, cocaine was observed to inhibit both testosterone and estradiol incorporation into the hypothalamus by approximately 50%. Long-term consequences of prenatal cocaine exposure were studied by injecting Sprague-Dawley dams twice daily with 3, 10 or 30 mg/kg of cocaine hydrochloride on days 15 through 20 of gestation and examining the offspring. In adulthood, cocaine-exposed males, but not females were found to exhibit significantly less marking behavior than controls. Cocaine-exposed males in the 10 mg/kg group tested for sex behavior exhibited demasculinization in some aspects of the behaviors tested. Measurement of plasma hormone levels in this group revealed elevated levels of plasma LH, but normal levels of FSH and testosterone. No differences were observed in cocaine-exposed males with respect to sex organ or adrenal weights, but thymus was approximately 25% smaller compared to control males at 80 days of age. In a separate experiment, dams were treated with 3 mg/kg of cocaine twice daily from days 15 through 21 of gestation and half of the male pups received additional injections twice a day for the first 5 days postnatally.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Cocaína/toxicidad , Estradiol/farmacocinética , Hipotálamo/metabolismo , Efectos Tardíos de la Exposición Prenatal , Conducta Sexual Animal/efectos de los fármacos , Testosterona/farmacocinética , Animales , Peso Corporal/efectos de los fármacos , Estradiol/fisiología , Femenino , Hipotálamo/efectos de los fármacos , Hipotálamo/crecimiento & desarrollo , Masculino , Tamaño de los Órganos/efectos de los fármacos , Embarazo , Ratas , Ratas Endogámicas , Testosterona/fisiologíaRESUMEN
OBJECTIVE: To examine the relationship between serum T levels and sexual function when T levels are varied in the normal male range by pharmacological means. Two groups of healthy men were treated with a depot form of GnRH agonist leuprolide acetate (Lupron depot; TAP Pharmaceuticals, Chicago, IL) on days 1 and 31 to suppress endogenous T production and either 4 (n = 6) or 8 (n = 5) mg/d T replacement by a sustained release, long-acting T microcapsule formulation on day 1. OUTCOME MEASURES: Sexual function was evaluated by daily logs of sexual activity and electroencephalogram-coupled nocturnal penile tumescence recording before and after 9 weeks of treatment. RESULTS: Serum T levels in 4 and 8 mg/d groups were at low and high ends of the normal male range, respectively (10.5 +/- 1.7 versus 26.5 +/- 3.4 nmol/L). The number and duration of rapid eye movement (REM) periods, latency to REM sleep, erections/REM period, magnitude, and duration of tumescence were not significantly different between the 4 and 8 mg groups. Sexual logs also did not show significant differences in overall scores or in subcategories of intensity of sexual feelings (libido) and sexual activity between the two doses. CONCLUSIONS: These data indicate that erectile function and sexual activity and feelings are restored by relatively low T levels. These data may help explain why some partially hypogonadal men continue to have normal sexual function and the absence of good correlation between serum T levels in the normal range and sexual function.
Asunto(s)
Leuprolida/farmacología , Erección Peniana/efectos de los fármacos , Conducta Sexual/efectos de los fármacos , Testosterona/sangre , Adulto , Preparaciones de Acción Retardada , Relación Dosis-Respuesta a Droga , Electroencefalografía/efectos de los fármacos , Humanos , Masculino , Persona de Mediana Edad , Erección Peniana/fisiología , Valores de Referencia , Conducta Sexual/fisiología , Sueño REM/efectos de los fármacosRESUMEN
Spontaneously hypertensive rats (SHRs) are typically less responsive to phasic noxious stimuli than are their normotensive controls. Here, we used the formalin test to compare behavioral and cardiovascular responses to persistent noxious stimuli. Hindpaw formalin injection produced exaggerated flinching, arterial pressure and heart rate responses in SHRs, suggesting that abnormalities in blood pressure control systems increase nociceptive responses to persistent noxious stimuli.
Asunto(s)
Conducta Animal/fisiología , Fenómenos Fisiológicos Cardiovasculares , Hipertensión/fisiopatología , Nociceptores/fisiología , Dimensión del Dolor/efectos de los fármacos , Ratas Endogámicas SHR/fisiología , Animales , Conducta Animal/efectos de los fármacos , Presión Sanguínea/fisiología , Sistema Cardiovascular/efectos de los fármacos , Formaldehído/administración & dosificación , Frecuencia Cardíaca/fisiología , Hipertensión/genética , Hipertensión/psicología , Inyecciones Subcutáneas , Masculino , Nociceptores/efectos de los fármacos , Ratas , Ratas Endogámicas WKY , Restricción FísicaRESUMEN
Object recognition may entail an incremental normalization process before access to canonical orientation representations, but is this process guided by prior access to object-centered representations? In Experiment 1, the authors showed observers figure-ground stimuli known to reflect access to, and output from, stored shape representations. The stimuli appeared in each of 6 different orientations, preceded by cues providing either (a) no information, (b) upright shape information only, (c) upright shape information plus orientation information (separately), or (d) shape information in the same orientation as the upcoming figure-ground test stimulus. Contrary to predictions by a postaccess account, the cues failed to eliminate orientation dependency in shape recognition. The results favor a preaccess account of the normalization process within the context of canonical orientation representations.
Asunto(s)
Atención , Señales (Psicología) , Aprendizaje Discriminativo , Ilusiones Ópticas , Orientación , Reconocimiento Visual de Modelos , Adulto , Femenino , Humanos , Masculino , Recuerdo MentalRESUMEN
Observers viewed upright and inverted versions of figure-ground stimuli, in which Gestalt variables specified that the center was figure. In upright versions, the surround was high in denotivity, in that most viewers agreed it depicted the same shape; in inverted versions, the surround was low in denotivity. The surround was maintained as figure longer and was more likely to be obtained as figure when the stimuli were upright rather than inverted. In four experiments, these effects reflected inputs to figure-ground computations from orientation-specific shape representations only. To account for these findings, a nonratiomorphic mechanism is proposed that enables shape recognition processes before figure-ground relationships are determined.
Asunto(s)
Atención , Área de Dependencia-Independencia , Ilusiones Ópticas , Orientación , Reconocimiento Visual de Modelos , Adulto , Aprendizaje Discriminativo , Femenino , Humanos , Masculino , Recuerdo Mental , Tiempo de ReacciónRESUMEN
In three experiments we investigated whether conscious object recognition is necessary or sufficient for effects of object memories on figure assignment. In experiment 1, we examined a brain-damaged participant, AD, whose conscious object recognition is severely impaired. AD's responses about figure assignment do reveal effects from memories of object structure, indicating that conscious object recognition is not necessary for these effects, and identifying the figure-ground test employed here as a new implicit test of access to memories of object structure. In experiments 2 and 3, we tested a second brain-damaged participant, WG, for whom conscious object recognition was relatively spared. Nevertheless, effects from memories of object structure on figure assignment were not evident in WG's responses about figure assignment in experiment 2, indicating that conscious object recognition is not sufficient for effects of object memories on figure assignment. WG's performance sheds light on AD's performance, and has implications for the theoretical understanding of object memory effects on figure assignment.
Asunto(s)
Memoria/fisiología , Reconocimiento Visual de Modelos/fisiología , Trastornos de la Percepción/psicología , Accidente Cerebrovascular/psicología , Anciano , Anciano de 80 o más Años , Señales (Psicología) , Femenino , Teoría Gestáltica , Humanos , Masculino , Persona de Mediana Edad , Modelos Psicológicos , Trastornos de la Percepción/etiología , Accidente Cerebrovascular/patologíaRESUMEN
In four experiments the conditions under which frequency judgments reflect the relative frequency of complex perceptual events were explored. Subjects viewed a series of 4 x 4 grids each containing seven items, which were letters and numbers in one of four typefaces. Later judgments of the relative frequency with which particular letters appeared in particular typefaces were unaffected by a warning about an upcoming frequency judgment task, but were affected by both the time available for processing the stimuli and the nature of the cover task subjects engaged in while viewing the grids. Frequency judgments were poor when exposure durations were less than 2 s and when the cover task directed subjects' attention merely to the locations of the items within the grids. Frequency judgments improved when the cover task directed subjects' attention to the identity of the stimuli, especially to the conjunction of letter and typeface. The results suggest that frequency estimation of complex stimuli may be possible only for stimuli that have been processed as phenomenal objects.
Asunto(s)
Percepción de Forma , Memoria , Reconocimiento Visual de Modelos , Atención , Humanos , Modelos Psicológicos , Factores de Tiempo , Campos VisualesRESUMEN
Four experiments examined implicit memory or priming effects on an object decision task in which subjects decided whether structurally possible or impossible novel objects could exist in three-dimensional form. Results revealed equivalent levels of priming for possible objects after 1 vs. 4 5-s exposures to the same structural encoding task (Experiment 1) and when objects were studied with a single structural encoding task or 2 different structural encoding tasks (Experiment 3). Explicit memory, by contrast, was greatly affected by both manipulations. However, priming of possible objects was not observed when Ss were given only a single 1-s exposure to perform a structural encoding task (Experiment 2). No evidence for priming of impossible objects was observed in any of the 4 experiments. The data suggest that object decision priming depends on a presemantic structural description system that is distinct from episodic memory.
Asunto(s)
Atención , Percepción de Profundidad , Recuerdo Mental , Ilusiones Ópticas , Reconocimiento Visual de Modelos , Retención en Psicología , Aprendizaje Discriminativo , Humanos , Orientación , Aprendizaje por Asociación de Pares , Semántica , Percepción del TamañoRESUMEN
In this journal, Palmer and Rock (1994) articulated a principle of perceptual organization calleduniform connectedness (UC); and they contended that previous investigators of perception had failed to realize the need for this organizing principle. The authors outlined a theory of perceptual organization that "places the principle of UC at center stage" (p. 38) in that UC was assigned the two privileged roles of (1) forming the fundamental units for later perceptual processes, and (2) yielding the postconstancy regions that correspond to environmental surfaces. In this commentary, I argue that the proposed theory entails a serial ordering of perceptual processes that is inconsistent with current evidence regarding figure-ground organization, stereo fusion, and object recogntion. In addition, I point out that Kurt Koffka (1935) recognized the need for a principle of unit formation similar to the one proposed by Palmer and Rock.
RESUMEN
We report syntheses of new amide-linked (di-penta)nucleoside analogues of antisense oligonucleotide components. Solution-phase coupling of 3'-(carboxymethyl)-3'-deoxy- and 5'-amino-5'-deoxynucleoside derivatives provides amide dimers. Activated [3'-(carboxymethyl)-3'-deoxy] units with a 5'-azido-5'-deoxy function provide "masked" 5'-amino-5'-deoxy residues for chain extension, and a 5'-O-DMT-protected unit provides the 5'-terminus for attachment to a phosphodiester linkage.
Asunto(s)
Amidas/química , Nucleósidos/síntesis química , Oligonucleótidos Antisentido/química , Oligonucleótidos/química , Nucleósidos/químicaRESUMEN
Ubiquitination of epidermal growth factor receptor (EGFR) is required for downregulation of the receptor by endocytosis. Impairment of this pathway results in constitutively active EGFR, which is associated with carcinogenesis, particularly in lung cancer. We previously demonstrated that the deubiquitinating enzyme ubiquitin-specific protease 2a (USP2a) has oncogenic properties. Here, we show a new role for USP2a as a regulator of EGFR endocytosis. USP2a localizes to early endosomes and associates with EGFR, stabilizing the receptor, which retains active downstream signaling. HeLa cells transiently expressing catalytically active, but not mutant (MUT), USP2a show increased plasma membrane-localized EGFR, as well as decreased internalized and ubiquitinated EGFR. Conversely, USP2a silencing reverses this phenotype. Importantly, USP2a prevents the degradation of MUT in addition to wild-type EGFR. Finally, we observed that USP2a and EGFR proteins are coordinately overexpressed in non-small cell lung cancers. Taken together, our data indicate that USP2a antagonizes EGFR endocytosis and thus amplifies signaling activity from the receptor. Our findings suggest that regulation of deubiquitination could be exploited therapeutically in cancers overexpressing EGFR.